Sangamo Therapeutics
Insider trading & Transactions

Last updated: 26 Apr 2013

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	26 Apr 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	26 Apr 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Sale	16 Apr 2013	LANPHIER EDWARD O II director director	Common Stock	190	N/A	N/A
Sale	15 Apr 2013	LANPHIER EDWARD O II director director	Common Stock	5,000	N/A	N/A
Sale	10 Apr 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	10 Apr 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Option	1 Apr 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	6,000	N/A	N/A
Sale	1 Apr 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	6,000	N/A	N/A
Option	1 Apr 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	6,000	N/A	N/A
Option	26 Mar 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	26 Mar 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	26 Mar 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	1 Mar 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	6,000	N/A	N/A
Option	1 Mar 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	6,000	N/A	N/A
Sale	1 Mar 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	6,000	N/A	N/A
Sale	28 Feb 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	28 Feb 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Sale	28 Feb 2013	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	28 Feb 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	26 Feb 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	26 Feb 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	26 Feb 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	1 Feb 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	6,000	N/A	N/A
Sale	1 Feb 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	6,000	N/A	N/A
Option	1 Feb 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	6,000	N/A	N/A
Sale	28 Jan 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	28 Jan 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	28 Jan 2013	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	24 Jan 2013	LANPHIER EDWARD O II director director	Common Stock	300	N/A	N/A
Sale	23 Jan 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	10,000	N/A	N/A
Option	23 Jan 2013	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	8,000	N/A	N/A
Sale	23 Jan 2013	LANPHIER EDWARD O II director director	Common Stock	8,300	N/A	N/A
Option	2 Jan 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	6,000	N/A	N/A
Option	2 Jan 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	6,000	N/A	N/A
Sale	2 Jan 2013	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	6,000	N/A	N/A
Sale	26 Dec 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	2,000	N/A	N/A
Option	26 Dec 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Option	26 Dec 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	10 Dec 2012	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	12,000	N/A	N/A
Sale	10 Dec 2012	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	12,000	N/A	N/A
Sale	10 Dec 2012	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	12,000	N/A	N/A
Sale	3 Dec 2012	LARSON JOHN WILLIAM director director	Common Stock	15,000	N/A	N/A
Sale	27 Nov 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	27 Nov 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	27 Nov 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	26 Nov 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	4,736	N/A	N/A
Sale	1 Nov 2012	LARSON JOHN WILLIAM director director	Common Stock	15,000	N/A	N/A
Sale	26 Oct 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	20,000	N/A	N/A
Option	26 Oct 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	26 Oct 2012	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A

Showing 650 to 700 of 1018 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Sangamo Therapeutics Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

Sangamo Therapeutics
Insider trading & Transactions